Stock listing
Lang & Schwarz:A2JRKN Ascletis Pharma, Inc. Aktie
German listing (Lang & Schwarz) of Ascletis Pharma, Inc. · home listing HKEX:1672
Follow Ascletis Pharma, Inc. into a list and get an email when it puts out news.
Home listing price · HKEX:1672
$4.37 HKD +0.00 (+0.1%)
Close on Nov 18, 2026 · This listing has no price on 6ix; the price shown is the home listing's, HKEX:1672
- Day range
- $4.18 – $4.50 HKDNov 18, 2026
- Volume
- 585,080 sharesNov 18, 2026
- Market cap
- $4.59B HKDAt the close on Nov 18, 2026 · price × 1.05B shares outstanding
- 52-week range
- $4.12 – $19.86 HKDLowest and highest trades, Nov 19, 2025 – Nov 18, 2026
- Traded on an average day
- $18.03M HKDMedian day 1.96M shares · last 3 months, Aug 18, 2026 – Nov 18, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| HKEX:1672 · Home | $4.37 HKD | +0.005 (+0.1%) | 585,080 | $4.365 | $4.50 | $4.175 | $4.365 | Close on Nov 18, 2026 |
| OTC:ASCLF | $0.625 USD | -0.095 (-13.2%) | 5,350 | $0.620 | $0.625 | $0.620 | $0.720 | Close on Nov 10, 2026 |
| Frankfurt:2VJ | €0.494 EUR | +0.010 (+2.1%) | — | €0.496 | €0.496 | €0.494 | €0.484 | Close on Nov 17, 2026 |
| Stuttgart:2VJ | €0.494 EUR | +0.012 (+2.5%) | — | €0.494 | €0.494 | €0.492 | €0.482 | Close on Nov 17, 2026 |
Daily closes
Last 3 months, Aug 18, 2026 – Nov 18, 2026 · HKEX:1672 · HKD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $4.37 | +0.005 | +0.1% | $4.365 | $4.50 | $4.175 | 585,080 | |
| $4.365 | +0.09 | +2.1% | $4.58 | $4.58 | $4.185 | 1,669,000 | |
| $4.275 | -0.42 | -8.9% | $4.50 | $4.63 | $4.215 | 1,547,000 | |
| $4.695 | -0.145 | -3.0% | $4.70 | $4.86 | $4.58 | 2,405,000 | |
| $4.84 | +0.065 | +1.4% | $4.775 | $5.08 | $4.66 | 2,872,000 | |
| $4.775 | +0.01 | +0.2% | $4.70 | $4.79 | $4.59 | 1,337,000 | |
| $4.765 | +0.06 | +1.3% | $4.78 | $4.865 | $4.635 | 1,528,000 | |
| $4.705 | +0.155 | +3.4% | $4.56 | $5.065 | $4.56 | 2,184,000 | |
| $4.55 | -0.345 | -7.0% | $4.71 | $4.755 | $4.505 | 2,459,000 | |
| $4.895 | +0.33 | +7.2% | $4.625 | $4.935 | $4.625 | 3,191,014 | |
| $4.565 | +0.255 | +5.9% | $4.31 | $4.63 | $4.115 | 4,014,000 | |
| $4.31 | -0.445 | -9.4% | $4.93 | $4.93 | $4.265 | 4,823,000 | |
| $4.755 | -0.145 | -3.0% | $4.685 | $4.87 | $4.63 | 1,929,000 | |
| $4.90 | -0.315 | -6.0% | $5.24 | $5.29 | $4.83 | 4,888,000 | |
| $5.215 | -0.22 | -4.0% | $5.46 | $5.65 | $5.17 | 1,627,000 | |
| $5.435 | +0.05 | +0.9% | $6.00 | $6.00 | $5.405 | 818,000 | |
| $5.385 | -0.19 | -3.4% | $5.51 | $5.57 | $5.34 | 965,000 | |
| $5.575 | -0.06 | -1.1% | $5.635 | $5.84 | $5.45 | 1,001,000 | |
| $5.635 | +0.12 | +2.2% | $5.52 | $5.72 | $5.435 | 1,339,660 | |
| $5.515 | -0.44 | -7.4% | $5.83 | $5.865 | $5.42 | 2,047,000 | |
| $5.955 | +0.225 | +3.9% | $5.90 | $6.245 | $5.89 | 2,388,000 | |
| $5.73 | -0.12 | -2.1% | $5.85 | $6.05 | $5.70 | 1,427,000 | |
| $5.85 | +0.065 | +1.1% | $5.75 | $6.24 | $5.73 | 3,419,000 | |
| $5.785 | -0.095 | -1.6% | $5.88 | $6.245 | $5.40 | 5,780,000 | |
| $5.88 | -0.82 | -12.2% | $6.64 | $6.88 | $5.785 | 4,129,000 | |
| $6.70 | -0.14 | -2.0% | $6.84 | $6.89 | $6.50 | 2,274,000 | |
| $6.84 | -0.12 | -1.7% | $6.965 | $7.24 | $6.65 | 2,842,000 | |
| $6.96 | -0.585 | -7.8% | $7.545 | $7.545 | $6.92 | 4,360,000 | |
| $7.545 | -0.905 | -10.7% | $8.455 | $8.455 | $7.395 | 4,170,000 | |
| $8.45 | -0.665 | -7.3% | $9.115 | $9.16 | $8.31 | 1,343,000 | |
| $9.115 | +0.965 | +11.8% | $8.47 | $9.20 | $8.47 | 1,613,000 | |
| $8.15 | +0.035 | +0.4% | $8.115 | $8.325 | $7.715 | 957,000 | |
| $8.115 | -0.25 | -3.0% | $8.25 | $8.30 | $7.675 | 1,164,000 | |
| $8.365 | +0.065 | +0.8% | $8.295 | $8.51 | $8.135 | 2,132,800 | |
| $8.30 | -0.25 | -2.9% | $8.55 | $8.94 | $8.295 | 1,441,000 | |
| $8.55 | -0.005 | -0.1% | $8.605 | $8.63 | $8.125 | 1,807,000 | |
| $8.555 | -0.20 | -2.3% | $8.755 | $8.755 | $8.45 | 595,000 | |
| $8.755 | -0.47 | -5.1% | $9.24 | $9.24 | $8.665 | 629,722 | |
| $9.225 | +0.225 | +2.5% | $9.07 | $9.29 | $8.945 | 1,337,566 | |
| $9.00 | -0.25 | -2.7% | $9.34 | $9.34 | $8.83 | 1,905,878 | |
| $9.25 | +0.28 | +3.1% | $8.97 | $9.60 | $8.97 | 3,132,822 | |
| $8.97 | +0.825 | +10.1% | $8.41 | $9.05 | $8.26 | 4,631,000 | |
| $8.145 | -0.095 | -1.2% | $8.245 | $8.525 | $8.02 | 1,528,000 | |
| $8.24 | -0.70 | -7.8% | $8.805 | $8.805 | $8.22 | 2,106,000 | |
| $8.94 | -0.06 | -0.7% | $9.28 | $9.555 | $8.315 | 4,468,150 | |
| $9.00 | -0.45 | -4.8% | $9.54 | $9.765 | $8.80 | 3,488,001 | |
| $9.45 | -0.60 | -6.0% | $9.585 | $10.13 | $9.45 | 3,977,700 | |
| $10.05 | -0.01 | -0.1% | $10.56 | $10.56 | $9.76 | 2,761,000 | |
| $10.06 | -0.12 | -1.2% | $10.52 | $10.75 | $10.00 | 1,768,000 | |
| $10.18 | -0.11 | -1.1% | $10.60 | $10.60 | $9.68 | 2,758,000 | |
| $10.29 | +0.20 | +2.0% | $10.22 | $10.72 | $9.23 | 9,258,574 | |
| $10.09 | -0.24 | -2.3% | $10.40 | $10.64 | $10.09 | 1,839,964 | |
| $10.33 | +0.33 | +3.3% | $10.30 | $10.39 | $9.74 | 1,960,610 | |
| $10.00 | +0.46 | +4.8% | $9.80 | $10.60 | $9.50 | 3,564,028 | |
| $9.54 | -0.48 | -4.8% | $9.705 | $9.915 | $9.51 | 1,005,000 | |
| $10.02 | -0.08 | -0.8% | $9.965 | $10.02 | $9.515 | 2,079,120 | |
| $10.10 | -0.30 | -2.9% | $10.50 | $10.56 | $9.90 | 1,182,000 | |
| $10.40 | +0.40 | +4.0% | $9.96 | $10.43 | $9.78 | 2,480,851 | |
| $10.00 | +0.125 | +1.3% | $9.90 | $10.30 | $9.81 | 2,059,000 | |
| $9.875 | +0.265 | +2.8% | $9.56 | $9.95 | $9.56 | 577,000 | |
| $9.61 | -0.41 | -4.1% | $10.30 | $10.45 | $9.565 | 1,888,000 | |
| $10.02 | -0.23 | -2.2% | $10.15 | $10.32 | $9.945 | 1,781,000 | |
| $10.25 | +0.425 | +4.3% | $9.61 | $10.62 | $9.565 | 1,515,500 | |
| $9.825 | -0.175 | -1.8% | $10.01 | $10.20 | $9.50 | 2,325,950 | |
| $10.00 | -0.45 | -4.3% | $10.37 | $10.56 | $9.985 | 1,803,000 |
- Ticker
- Lang & Schwarz:A2JRKN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Nov 17, 2026
Voluntary announcement - ascletis submits IND application to the U.S. FDA for ASC36_37O FDC, a potentially first-in-class once-weekly oral quadruple peptide agonist targeting amylin receptor, GLP-1R, GIPR and GCGR, for the treatment of obesity
Latest deck · November 2026
Investor Presentation (November 2026)
Investor deck · 23 slides
Latest news
Voluntary announcement - ascletis submits IND application to the U.S. FDA for ASC36_37O FDC, a potentially first-in-class once-weekly oral quadruple peptide agonist targeting amylin receptor, GLP-1R, GIPR and GCGR, for the treatment of obesity
Nov 17, 2026
Closed $4.37 (+0.1%) on Nov 18, 2026
Voluntary announcement - ascletis highlights oral and long-acting injectable anti-obesity preclinical studies at obesityweek 2026
Nov 16, 2026
Closed $4.37 (+2.1%) on Nov 17, 2026
Voluntary announcement - ascletis submits IND application to the U.S. FDA for ASC30_39 FDC, a potentially first-in-class oral small molecule fixed-dose combination of GLP-1R agonist and selective amylin receptor agonist, for the treatment of obesity
Nov 11, 2026
Closed $4.84 (+1.4%) on Nov 12, 2026
Next Day Disclosure Return
Nov 6, 2026
Closed $4.71 (+3.4%) on Nov 9, 2026
Grant of share options
Nov 4, 2026
Closed $4.90 (+7.2%) on Nov 5, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Nov 4, 2026
Closed $4.90 (+7.2%) on Nov 5, 2026
Voluntary announcement - ascletis to present study results of oral small molecule GIPR agonist ASC48 and GLP-1R/GIPR/GCGR triple peptide agonist ASC37 at ObesityWeek 2026
Nov 2, 2026
Closed $4.31 (-9.4%) on Nov 3, 2026
Voluntary announcement - ascletis' oral small molecule GLP-1, ASC30, demonstrated placebo-adjusted HBA1C reduction of 1.7% at 12 weeks from its U.S. phase II study in participants with diabetes
Oct 28, 2026
Closed $5.22 (-4.0%) on Oct 29, 2026
Decks
Investor Presentation (November 2026)
Investor deck · 23 slides · November 2026
Investor Presentation (October 2026)
Investor deck · 23 slides · Oct 21, 2026
Investor Presentation (August 2026)
Investor deck · 22 slides · August 2026
EASD 2026
Conference · 8 slides · 2026
Ascletis Pharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 57 in the last 12 months · 88 in all · newest Nov 17, 2026 · oldest 2025
- Decks
- 6 decks · latest November 2026
Where Ascletis Pharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| HKEX:1672 歌禮製藥 · Home listing | HKEX | Hong Kong | HKD |
| Tradegate:2VJ | Tradegate | Germany | EUR |
| OTC:ASCLF | OTC | United States | USD |
| LS Exchange:A2JRKN | LS Exchange | Germany | EUR |
| gettex:2VJ | gettex | Germany | EUR |
| Lang & Schwarz:A2JRKN · This page | Lang & Schwarz | Germany | EUR |
| Frankfurt:2VJ | Frankfurt | Germany | EUR |
| Dusseldorf:2VJ | Dusseldorf | Germany | EUR |
| Munich:2VJ | Munich | Germany | EUR |
| Stuttgart:2VJ | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Ascletis Pharma, Inc.